## 

||Page||
|---|---|---|
|Report ofthe trustees|1 to|12|
|Report ofthe independent<br>auditors|13 to|16|
|Statement offinancial activities|17||
|Balance sheet|18||
|Cash flow statement|19||
|Notes tothe cash flow statement|20||
|Notes tothe financial statements|21 to|36|





## 

## 

## 

## 

## 



## 

## 

## 

## 



## 

## 

## 

## 

## 



## 



## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 



## 

## 

## 



## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 



## 

## 

## 

## 



## 

## 



## 

## 

## 

## 



## 

## 

## 

## 

## 



## 



## 



## 

|||||||2021|2020|
|---|---|---|---|---|---|---|---|
||||Unrestricted|Restricted|Endowment|Total|Total|
||||fund|funds|fund|funds|funds|
||Notes||5|5|5|5|5|
|INCOME AND||||||||
|ENDOWMENTS<br>FROM||||||||
|Donations and legacies|3||156,226|310,532||466,758|455,001|
|Charitable<br>activities||||||||
|ILDS activities|||||||7,423|
|Investment<br>income|4||132765||22 093|154858|85785|
|Total|||288,991|310,532|22,093|621,616|548,209|
|EXPENDITURE ON||||||||
|Raising funds|6||387,160||2,935|390,095|(49,056)|
|Charitable<br>activities|7|||||||
|Support the operational||||||||
|costs ofthe RDTC in Moshi|||24,234|85,758||109,992|101,972|
|IFD general activities|||125,598|85,882||211,480|8,525|
|Student sponsorship||||125,568||125,568|117,800|
|ILDSactivities|||156,442|||156,442|7,401|
|Community<br>Skin Health Journal|||8,575|52,779||61,354|3,936|
|Global Psoriasis Atlas|||59,821|2,271||62,092|249,633|
|World Congress ofDermatology|||114,342|||114,342|(40,198)|
|WHO activities|||180,147|||180,147|17,379|
|Total|||1,056,319|352,258|2,935|1,411,512|417,392|
|Net gains/(losses)<br>on<br>investments|||64 722||~34837)|29 885|567 744|
|NET||||||||
|INCOME/(EXPENDITURE)|||(702,606)|(41,726)|(15,679)|(760,011)|698,561|
|Transfers between funds|17|~237195||137195||||
|Net movement<br>in funds|||(839,801)|95,469|(15,679)|(760,011)|698,561|
|RECONCILIATION<br>OF FUNDS||||||||
|Total funds brought forward||15,219,393||181,943|1,149,240|16,550,576|15,852,015|
|TOTAL FUNDS CARRIED<br>FORWARD||||~277412|1.133.561|~aM5|~~76|





## 

## 

||||||||2021|2020|
|---|---|---|---|---|---|---|---|---|
|||||Unrestricted|Restricted|Endowment|Total|Total|
|||||fund|funds|fund|funds|funds|
|||Notes||5|5|5|5|5|
|FIXEDASSETS|||||||||
|Tangible assets||13||6,823|||6,823|6,284|
|Investments||14|11698492|||687517|12386 009|~58437 II|
||||11,705,315|||687,517|12,392,832|5,849,992|
|CURRENT ASSETS|||||||||
|Debtors||15||33,135|||33,135|13,517|
|Cash at bank|and in hand|||26797III|277412|446044|3403157|10750015|
|||||2,712,836|277,412|446,044|3,436,292|10,763,532|
|CREDITORS|||||||||
|Amounts<br>falling due within|||||||||
|one year||16||(38,559)|||(38,559)|(62,948)|
|NET CURRENT ASSETS||||2 674 277|277 412|446 044|3397733|10700584|
|TOTAL ASSETS LESS|||||||||
|CURRENT LIABILITIES|||14,379,592||277,412|1,133,561|15,790,565|16,550,576|
|NET ASSETS|||~14 7~||~~|~561|~L5@||
|FUNDS||17|||||||
|Unrestricted|funds||||||14,379,592|15,219,393|
|Restricted funds|||||||277,412|181,943|
|Endowment|funds||||||1133561|1149240|



## 




## 

## 

||||2021|2020|
|---|---|---|---|---|
||Notes||5|5|
|Cash flows from operating<br>activities<br>Cash generated<br>from operations||1|J7.005 896)|6396 178|
|Net cash (used in)/provided<br>by operating||activities|J1005896)|6396 178|
|Cash flows from investing<br>activities|||||
|Purchase oftangible<br>fixed assets|||(2,562)|(2,955)|
|Purchase offixed asset investments|||(12,414,303)|(5,885,921)|
|Sale offixed asset investments|||5,901,887|5,963,847|
|Interest received|||154858|85 785|
|Net cash (used in)/provided<br>by investing||activities|J6360120)|160756|
|Cash flows from financing activities|||||
|Income attributable<br>to endowment<br>Expenditure<br>attributable<br>to endowment|||22,093<br>~2935|22,464<br>~6842)|
|Net cash provided<br>by financing<br>activities|||19158|15623|
|Change<br>in cash and cash equivalents|in||||
|the reporting<br>period|||(7,346,858)|6,572,557|
|Cash and cash equivalents<br>at the|||||
|beginning ofthe reporting<br>period|||1D750 D15|4 177458|
|Cash and cash equivalents<br>atthe end|||||
|ofthe reporting<br>period|||||





## 

## 

|RECONCILIATION<br>OFNET (EXPENDITURE)/INCOME|RECONCILIATION<br>OFNET (EXPENDITURE)/INCOME|TO NET CASH|FLOW FROM OPERATING|FLOW FROM OPERATING|
|---|---|---|---|---|
|ACTIVITIES|||||
||||2021|2020|
||||5|5|
|Net (expenditure)/income<br>forthe reporting|period|(as per the|||
|Statement offinancial activities)|||(760,011)|698,561|
|Adjustments<br>for:|||||
|Depreciation<br>charges|||2,023|1,817|
|Gain on investments|||(29,885)|(567,744)|
|Loss on disposalof fixed assets||||428|
|Interest received|||(154,858)|(85,785)|
|Income attributable<br>to endowment|||(22,093)|(22,464)|
|Expenditure<br>attributable<br>to endowment|||2,935|6,841|
|(Increase)/decrease<br>in debtors<br>(Decrease)/increase<br>in creditors|||(19,618)<br>~24 3852|6,359,898<br>4 626|
|Net cash (used in)/provided<br>by operations|||~MS|~86~7|



## 

||At 1/1/21|Cash flow|At 31/12/21|
|---|---|---|---|
||5|5|5|
|Net cash||||
|Cash at bank and in hand|10750015|~7346 858I|3403157|
||10750015|~73468582|3403157|
|Total|~Z5L()2.'!|J~LaLI|~4~1|





## 

## 



## 

## 

## 

## 

## 



## 

## 

## 

## 

## 



## 

## 

## 

## 

|DONATIONS<br>AND LEGACIES|||
|---|---|---|
||2021|2020|
||5|5|
|Donations|310,532|295,428|
|Subscriptions|156226|159573|





## 

|4.|INVESTMENT INCOME|||||
|---|---|---|---|---|---|
|||||2021|2020|
|||||S|S|
||Portfolio income|||154,829|85,650|
||Bank interest|||29|135|
||||||~85 785|
|5.|INCOME FROM CHARITABLE|ACTIVITIES||||
|||||2021|2020|
|||Activity||5|9|
||World Congress fees|ILDS activities||||
|6.|RAISING FUNDS|||||
||RAISING DONATIONS AND LEGACIES|||||
|||||2021|2020|
||Support costs|||S|S<br>(~11)|
||An analysis ofsupport costs is provided||in note 8.|||
||INVESTMENT MANAGEMENT|COSTS||||
|||||2021|2020|
||Portfolio management|||S~09|S<br>~1445|
||Aggregate<br>amounts|||||





## 

## 

|CHARITABLE ACTIVITIE|S COSTS||||
|---|---|---|---|---|
||||Support||
|||Direct|costs (see||
|||Costs|note 8)|Totals|
||||5||
|Support the operational|costs ofthe||||
|RDTC in Moshi||85,758|24,234|109,992|
|IFD general<br>activities||85,882|125,598|211,480|
|Student sponsorship||125,568||125,568|
|ILDS activities||33,968|122,474|156,442|
|Community<br>Skin Health|Journal|52,779|8,575|61,354|
|Global Psoriasis Atlas||2,271|59,821|62,092|
|World Congress of Dermatology||5,052|109,290|114,342|
|WHO activities||102666|77441|180147|
|||||~121417|



|Support the RDTC in Moshi|583,821|
|---|---|
|IFD General activities|585,883|
|Student sponsorship|5125,568|
|ILDSActivities|$30,000|



## 

|||||||Governance||
|---|---|---|---|---|---|---|---|
|||||Management||Finance|costs|
|||||Totals||||
|||||5|5|5|5|
|Raising donations||and|legacies|279,079|77,265|3,562|359,906|
|Support the operational|||costs ofthe|||||
|RDTC in Moshi||||17,955|6,002|277|24,234|
|IFD general activities||||88,595|35,372|1,631|125,598|
|ILDS activities||||93,459|27,737|1,278|122,474|
|Community<br>Skin||Health|Journal|6,490|1,993|92|8,575|
|GlobalPsoriasis|Atlas|||50,651|8,766|404|59,821|
|World Congress||of Dermatology||81,967|26,119|1,204|109,290|
|WHO activities||||62 653|14175|653|77481|





## 

## 

|Support cost||, inclu|ded<br>in t|he above, are a|s follows:||||
|---|---|---|---|---|---|---|---|---|
||||||Support||||
||||||the||||
|||||Raising|operational|||Community|
|||||donations|costs of|IFD||Skin|
|||||and|the RDTC|general|ILDS|Health|
|||||legacies|in Moshi|activities|activities|Journal|
|||||5|5|5|5|5|
|Administration||salaries||191,328|11,486|51,999|62,306|4,175|
|Social security||||17,497|1,013|4,428|5,929|501|
|Pensions||||7,629|592|3,491|2,737|197|
|Office rent and related||||5,552|431|2,543|1,994|143|
|costs|||||||||
|Recruitment|fees|||16,340|1,269|7,481|5,866|422|
|Meetings and||travel||649|50|297|233|17|
|Website||||4,863|378|2,228|1,747|126|
|Postage and stationery||||472|37|217|170|12|
|Branding||||7,124|554|3,265|2,561|184|
|Sundries||||119|9|54|42|3|
|Legal, professional|||and||||||
|accountancy||||23,778|1,847|10,888|8,539|614|
|Training||||1,674|130|765|600|43|
|President support costs||||2,054|159|939|735|53|
|Bank charges||||1,402|109|640|502|36|
|Foreign exchange||||75,069|5,832|34,369|26,952|1,937|
|variance|||||||||
|Depreciation||oftangible|||||||
|fixed assets||||794|61|363|283|20|
|Loss on sale oftangible|||||||||
|fixed assets|||||||||
|Auditors'<br>remuneration||||3,562|277|1,631|1,278|92|
|Board meeting costs|||||||||





## 

## 

||||||||2021|2020|
|---|---|---|---|---|---|---|---|---|
||||||World||||
|||||Global|Congress||||
|||||Psoriasis|of|WHO|Total|Total|
|||||Atlas|Dermatology|activities|activities|activities|
|||||S|S|S|S|S|
|Administration|salaries|||41,460|53,334|44,912|461,000|313,207|
|Social security||||1,219|4,878|4,855|40,320|26,715|
|Pensions||||865|2,579|1,399|19,489|15,959|
|Office rent and related||||630|1,878|1,018|14,189|16,046|
|costs|||||||||
|Recruitment|fees|||1,854|5,524|2,997|41,753|3,071|
|Meetings<br>and travel||||74|219|119|1,658|8,506|
|Website||||552|1,646|893|12,433|21,741|
|Postage and|stationery|||54|160|86|1,208|486|
|Branding||||809|2,411|1,307|18,215|44,661|
|Sundries||||13|40|21|301|436|
|Legal, professional||and|||||||
|accountancy||||2,698|8,040|4,364|60,768|56,879|
|Training||||190|565|306|4,273|8,927|
|President support||costs||233|693|376|5,242|3,158|
|Bank charges||||159|474|257|3,579|2,974|
|Foreign exchange||||8,517|25,378|13,773|191,827|(815,179)|
|variance|||||||||
|Depreciation|oftangible||||||||
|fixed assets||||90|267|145|2,023|1,817|
|Loss on sale oftangible|||||||||
|fixed assets||||||||428|
|Auditors'<br>remuneration<br>Board meeting costs|||||1,204|653|9,101|11,213<br>~22)|
|||||59821||7 481||(22L922)|
|NET INCOME/(EXPENDITURE)|||||||||
|Net income/(expenditure)|||is|stated after|charging/(crediting):||||
||||||||2021|2020|
||||||||S|S|
|Auditors'<br>remuneration|||||||9,101|11,213|
|Depreciation|-owned assets||||||2,023|1,817|
|Deficit on disposal||offixed|assets|||||428|





## 

## 

## 

## 

||||2021|2020|
|---|---|---|---|---|
||||5|5|
|Agency and subcontract|staff||19,300|11,563|
|Wages and salaries|||440,573|301,807|
|Social security costs|||40,318|26,553|
|Employer contributions|todefined contribution|pension schemes|19488|15956|
||||~7|~87|





## 

|12.|COMPARATIVES FOR THE STATEMENT OF FINANCIAL ACTIVITIES|COMPARATIVES FOR THE STATEMENT OF FINANCIAL ACTIVITIES|COMPARATIVES FOR THE STATEMENT OF FINANCIAL ACTIVITIES|COMPARATIVES FOR THE STATEMENT OF FINANCIAL ACTIVITIES|COMPARATIVES FOR THE STATEMENT OF FINANCIAL ACTIVITIES|||
|---|---|---|---|---|---|---|---|
|||||Unrestricted|Restricted|Endowment|Total|
|||||fund|funds|fund|funds|
|||||5|5|5|5|
||INCOME AND ENDOWMENTS||FROM|||||
||Donations<br>and legacies|||159,584|295,417||455,001|
||Charitable<br>activities|||||||
||ILDS activities|||7,423|||7,423|
||Investment<br>income|||63321||22 464|85 785|
||Total|||230,328|295,417|22,464|548,209|
||EXPENDITURE ON|||||||
||Raising funds|||(55,897)||6,841|(49,056)|
||Charitable<br>activities|||||||
||Support the operationa|Icosts ofthe||||||
||RDTC in Moshi|||(5,831)|107,803||101,972|
||IFDgeneral activities|||(110,738)|119,263||8,525|
||Student sponsorship||||117,800||117,800|
||ILDS activities|||7,401|||7,401|
||Community<br>Skin Health|Journal||(11,571)|15,507||3,936|
||Global Psoriasis atlas|||3,894|245,739||249,633|
||World Congress ofDermatology|||(40,198)|||(40,198)|
||WHO activities|||17,379|||17,379|
||Total|||(195,561)|606,112|6,841|417,392|
||Net gains on investments|||525 259||42 485|567 744|
||NET INCOME/(EXPENDITURE)|||951,148|(310,695)|58,108|698,561|
||Transfers between funds|||~252 020|207 397|~55377)||
||Net movement<br>in funds|||799,128|(103,298)|2,731|698,561|
||RECONCILIATION<br>OF FUNDS|||||||
||Total funds brought forward|||14,420,265|285,241|1,146,509|15,852,015|
||TOTAL FUNDS CARRIED|FORWARD||M~|~|~80|~55~6|





## 

## 

|13.|TANGIBLE FIXEDASSETS||
|---|---|---|
|||Office|
|||equipment|
|||$|
||COST||
||At 1stJanuary 2021|16,007|
||Additions|2562|
||At 31stDecember 2021|18569|
||DEPRECIATION||
||At 1stJanuary 2021|9,723|
||Charge for year|~2023|
||At 31stDecember 2021|11746|
||NET BOOK VALUE||
||At 31stDecember 2021||
||At 31stDecember 2020||
|14.|FIXEDASSET INVESTMENTS||
|||Unlisted|
|||investments|
||MARKET VALUE||
||At 1stJanuary 2021|5,843,708|
||Additions<br>&reinvested|12,414,303|
||Disposals|(6,101,688)|
||Revaluations|229 686|
||At 31stDecember 2021|12386009|
||NET BOOK VALUE||
||At 31stDecember 2021||
||At 31stDecember 2020||





## 

|15.|DEBTORS:AMOUNTS|DEBTORS:AMOUNTS|FALLING DUE WITHIN ONE YEAR|||
|---|---|---|---|---|---|
|||||2021|2020|
|||||S|S|
||Trade debtors|||(1,373)|4,415|
||Prepayments<br>and accrued income|||34508|9 102|
|16.|CREDITORS: AMOUNTS<br>FALLING DUE WITHIN ONE YEAR|||||
|||||2021|2020|
|||||S|S|
||Trade creditors|||5,306|1,769|
||Other creditors|||11,044|1,303|
||Accruals|and deferred|income|22209|59876|
||Deferred|subscription|income:|||
|||||2021|2020|
||||||S|
||Deferred|subscription|income brought forward|640|500|
||Released|in year||(400)|(200)|
||Received|in advance during the year|||340|
||Deferred|subscription|income carried forward|||





## 

## 

## 

|MOVEMENT<br>IN||FUNDS|||||||||
|---|---|---|---|---|---|---|---|---|---|---|
||||||||Net|Transfers|||
||||||||movement|between||At|
|||||||At 1/1/21|in funds||funds|31/12/21|
|||||||S||||S|
|Unrestricted<br>funds|||||||||||
|General<br>fund||||||15,219,393|(702,606)|(137,195)||14,379,592|
|Restricted funds|||||||||||
|IFD General|||||||(36,643)||36,643||
|IFD RDTC|||||||(24,117)||24,117||
|IFD Community||Skin Health Journal|||||(51,206)||51,206||
|IFD Persons with Albinism|||||||(15,229)||15,229||
|IFD IACS|||||||(10,000)||10,000||
|ILDSGlobal Psoriasis Atlas||||||141343|95469|||277412|
|||||||181,943|(41,726)|137,195||277,412|
|Endowment<br>funds|||||||||||
|IFD (Moshi RDTC) Endowment||||Fund||1,149,240|(15,679)|||1,133,561|
|TOTALFUNDS|||||||~7&11)=||=|~9()'i'|
|Net movement|in funds,||included||in the above are as follows:||||||
|||||||Incoming|Resources|Gains and||Movement|
|||||||resources|expended||losses|in funds|
|||||||S|5||||
|Unrestricted<br>funds|||||||||||
|General<br>fund||||||288,991|(1,056,319)|64,722||(702,606)|
|Restricted funds|||||||||||
|IFD General||||||24,010|(60,653)|||(36,643)|
|IFD RDTC||||||187,209|(211,326)|||(24,117)|
|IFD Community||Skin Health Journal||||1,573|(52,779)|||(51,206)|
|IFD Persons with||Albinism|||||(15,229)|||(15,229)|
|IFD IACS<br>ILDS Global Psoriasis Atlas||||||97740|(10,000)<br>~2271)|||(10,000)<br>95469|
|||||||310,532|(352,258)|||(41,726)|
|Endowment<br>funds|||||||||||
|IFD (Moshi RDTC) Endowment||||Fund||22,093|(2,935)|(34,837)||(15,679)|
|TOTALFUNDS|||||||(~411 12)|~||~611)|





## 

## 

## 

|||||||Net|Transfers||
|---|---|---|---|---|---|---|---|---|
|||||||movement|between|At|
||||||At 1/1/20|in funds|funds|31/12/20|
||||||5|||5|
|Unrestricted|funds||||||||
|General fund||||14,420,265||951,148|(152,020)|15,219,393|
|Restricted funds|||||||||
|IFD General||||||(66,359)|66,359||
|IFD RDTC||||||(96,771)|96,771||
|IFD Community||Skin Health Journal||||(14,315)|14,315||
|IFD Persons|with Albinism||||48|(20,000)|19,952||
|IFD IACS<br>ILDSGlobal Psoriasis Atlas|||||285 153|(10,000)<br>~103250|10,000|~181943|
||||||285,241|(310,695)|207,397|181,943|
|Endowment|funds||||||||
|IFD (Moshi RDTC) Endowment|||Fund|1,146,509||58,108|(55,377)|1,149,240|
|TOTAL FUNDS||||||ILK';||~Ksz6|
|Comparative|net movement||in funds,|included|in the above are as follows:||||
||||||Incoming|Resources|Gains and|Movement|
||||||resources|expended|losses|in funds|
||||||5|5|||
|Unrestricted|funds||||||||
|General fund|||||230,328|195,561|525,259|951,148|
|Restricted funds|||||||||
|IFD General|||||22,904|(89,263)||(66,359)|
|IFD RDTC|||||128,832|(225,603)||(96,771)|
|IFD Community||Skin Health Journal|||1,192|(15,507)||(14,315)|
|IFD Persons with||Albinism||||(20,000)||(20,000)|
|IFD IACS||||||(10,000)||(10,000)|
|ILDSGlobal Psoriasis Atlas|||||~142489|(245739)||(103250)|
||||||295,417|(606,112)||(310,695)|
|Endowment|funds||||||||
|IFD (Moshi RDTC) Endowment|||Fund||22,464|(6,841)|42,485|58,108|
|TOTAL FUNDS|||||54L209|(~)|~|6RKRG|





## 

## 



## 

## 

## 

